Posted in | News | Nanomaterials

Malvern Wins Fifth Queen’s Award for Development of Zetasizer Nano Particle Characterization Systems

Now entering its fortieth year in business, materials characterization specialist Malvern Panalytical is celebrating winning its fifth Queen’s Award, a significant achievement that reflects the drive and commitment of everyone in this high-tech company.

Details of the award were announced on the occasion of Her Majesty The Queen’s birthday on 21st April 2010. Malvern Panalytical is to receive the Queen’s Award for Enterprise in the category Innovation, in recognition of the company’s continuous innovation and development of its award winning Zetasizer Nano range of particle characterization systems.

Malvern Panalytical’s Managing Director Paul Walker says that the award is a huge tribute to the whole company. “I am immensely pleased for the entire Malvern Panalytical’ team,” he said. “Over the years we have nurtured a culture of enterprise, initiative and innovation, encouraging both creativity and technical excellence, where everything we do is focused on meeting the needs of our customers. This extends beyond the vital technical product innovation, and everyone has a part to play in delivering the whole product – from administration, sales, training, technical service and high level applications support, right through to ensuring round-the-clock global availability of information across the web. Innovation does not take place in isolation and I want to thank everyone at Malvern Panalytical, in the UK and all around the world, for their contribution to making this award possible.”

The Queen's Awards for Enterprise are the UK's most prestigious Awards for business performance. Malvern Panalytical has previously received: The Queen’s Award for Technology in 1977; The Queen’s Award for Export in 1981; The Queen’s Award for Export and Technology 1988; and The Queen’s Award for Enterprise in International Trade in 2006.

The Zetasizer Nano series is a family of analytical instruments that measure a number of the physical characteristics of nanoparticles and proteins, such as particle size, zeta potential and molecular weight, easily and quickly. Designed to meet demanding market requirements for extensive functionality while offering true ease of use, the Zetasizer Nano has been a commercial success from the outset, a key factor being the simplicity of the user interaction required to generate, understand and apply sophisticated measurement data. Launched in 2003, the Zetasizer Nano was the culmination of the development of earlier highly complex systems. Ongoing work has added new software and accessories that have brought additional functionality and considerably extended the system’s applications.

Source: http://www.malvern.com/

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Malvern Panalytical. (2024, February 13). Malvern Wins Fifth Queen’s Award for Development of Zetasizer Nano Particle Characterization Systems. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=17158.

  • MLA

    Malvern Panalytical. "Malvern Wins Fifth Queen’s Award for Development of Zetasizer Nano Particle Characterization Systems". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=17158>.

  • Chicago

    Malvern Panalytical. "Malvern Wins Fifth Queen’s Award for Development of Zetasizer Nano Particle Characterization Systems". AZoNano. https://www.azonano.com/news.aspx?newsID=17158. (accessed November 21, 2024).

  • Harvard

    Malvern Panalytical. 2024. Malvern Wins Fifth Queen’s Award for Development of Zetasizer Nano Particle Characterization Systems. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=17158.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.